Products Affected - Description
Nicardipine hydrochloride injection, American Regent
2.5 mg/mL, 10 mL vial, 10 count, NDC 40042-0047-10
Nicardipine hydrochloride injection, Caraco
2.5 mg/mL, 10 mL ampule, 10 count, NDC 41616-0882-44
Nicardipine hydrochloride injection, Mylan Institutional
2.5 mg/mL, 10 mL vial, 10 count, NDC 67457-0224-10
Nicardipine hydrochloride injection, Sandoz
2.5 mg/mL, 10 mL vial, 10 count, NDC 00781-3204-95
2.5 mg/mL, 10 mL vial, 10 count, NDC 00781-9324-95
Nicardipine hydrochloride injection, Wockhardt
2.5 mg/mL, 10 mL vials, NDC 64679-0631-02
Cardene, Cornerstone Therapeutics
2.5 mg/mL, 10 mL ampule, NDC 24477-0030-25–discontinued
Reason for the Shortage
- American Regent has nicardipine injection on shortage due to manufacturing delays.
- Caraco could not provide a reason for the shortage.
- Chiesi acquired Cornerstone Therapeutics and changed the companies name in 2014. Cardene ampules were discontinued in March 2014.
- Mylan Institutional could not provide a reason for the shortage.
- Sandoz could not provide a reason for the shortage.
- Wockhardt has nicardipine on shortage due to an FDA import alert.
Nicardipine hydrochloride injection, West-Ward
2.5 mg/mL, 10 mL vial, 10 count (NDC 00143-9689-10)
40 mg/200 mL in 5% dextrose, 10 count (NDC 24477-0324-02)
40 mg/200 mL in 0.9% sodium chloride, 10 count (NDC 24477-0323-02)
20 mg/200 mL in 5% dextrose, 10 count (NDC 24477-0312-02)
20 mg/200 mL in 0.9% sodium chloride, 10 count (NDC 24477-0311-02)
Estimated Resupply Dates
- American Regent has nicardipine hydrochloride injection on back order and the company cannot estimate a release date.
- Caraco has temporarily discontinued nicardipine 2.5 mg/mL 10 mL ampules and the company cannot estimate when product will return.
- Mylan Institutional has nicardipine on back order and the company cannot estimate a release date.
- Sandoz has nicardipine 2.5 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
- Wockhardt has nicardipine 2.5 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
West-Ward’s nicardipine hydrochloride injection 2.5 mg/mL 10 mL vials contain benzoic acid and sodium chloride as excipients compared to the Cardene 2.5 mg/mL 10 mL ampules and other generic nicardipine 2.5 mg/mL 10 mL vials and ampules, which contain citric acid and sorbitol as excipients.
June 1, March 2, 2015; December 1, September 15, July 2 and 22, May 1 and 30, March 3, February 21, January 17, 2014; December 4 and 27, October 25, September 12, 23, and 25, August 1 and 22, June 28, May 31, April 10, March 14, February 7, 2013; December 12, September 6, June 29, March 29, February 15, January 20, 2012; November 18, September 21, August 11, June 9, April 27, March 30, January 21, 2011; November 12, October 4, September 15, July 30, June 8, May 5, March 19, February 22, January 12, 2010; November 6, September 21, August 6, June 9, April 20, March 9, February 18, January 12, 2009; December 2, November 10, October 17, 2008, University of Utah, Drug Information Service. Copyright 2015, University of Utah, Drug Information Service.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins